rabbit polyclonal anti-cd55  (Millipore)

Journal: Nanomaterials

Article Title: A Closed-Loop Autologous Erythrocyte-Mediated Delivery Platform for Diabetic Nephropathy Therapy

doi: 10.3390/nano12203556

Figure Lengend Snippet: Changes in blood parameters during the hemodialysis process of the CAER platform. ( A ) Mean concentration changes in unencapsulated INS in the serum. ( B ) Mean concentration changes in unmodified GOx from GOx-INS@ERs. ( C , D ) Effects of hemodialysis on the INS concentration and GOx in the GOx-INS@ERs. ( E ) CREA, BUN, Ca 2+ , and K + concentrations before and after hemodialysis. ( F ) Surface expression levels of CD55 and CD59 on GOx-INS@ERs and natural ERs measured by flow cytometry. ** p < 0.01.

Article Snippet: Rabbit anti-CD55 antibody (bs-1552R), rabbit anti-CD59 antibody (bs-1638R), and mouse anti-rabbit IgM/FITC antibody (bs-0369M-FITC) were from BIOSS (Beijing, China).

Techniques: Concentration Assay, Expressing, Flow Cytometry

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: Expression of CD55 mRNA and protein in normal thymus, thymoma, and TSCC. The expression levels of CD55 mRNA ( A ) and protein ( B ) were significantly elevated progressively in normal thymus tissue, thymoma, and TSCC

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Expressing

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: Intensities of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: low expression ( B , 40×; b, 200×); scored 2: moderate expression ( C , 40×; c, 200×); scored 3: high expression ( D , 40×; d, 200×)

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Expressing

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: Proportion of CD55 expression in TETs (IHC) scored 0: negative expression ( A , 40×; a, 200×); scored 1: 1% − 30% positive cells ( B , 40×; b, 200×); scored 2: 30% − 60% positive cells ( C , 40×; c, 200×); scored 3: ≥ 60% positive cells ( D , 40×; d, 200×)

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Expressing

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: Kaplan-Meier Survival Analysis in TETs The results demonstrated that PFS of TETs was closely related to CD55 mRNA ( A , p < 0.0001), CD55 protein ( B , p < 0.0001), tumor completeness of resection ( C , p < 0.0001), histological type ( D , p < 0.0001), Masaoka-Koga stage ( E , p < 0.0001), and adjuvant therapy ( F , p = 0.0009), but no with gender ( G , p = 0.1805) or MG ( H , p = 0.7269)

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Adjuvant

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: The relationship between CD55 and the clinical pathological features of patients The expression levels of CD55 mRNA and protein were higher in R1/R2 group ( A ), higher histological grade ( B ), Masaoka-Koga stage III/IV ( C ), adjuvant therapy ( D ) compared with the corresponding R0 group, normal thymus tissues, and stage I/II, and no-adjuvant therapy. Moreover, the expression of CD55 protein was significantly higher expressed in ≥ 60 years compared with ˂60 years ( E ). Additionally, CD55 protein expression was higher in males than that in females ( F ), whereas CD55 mRNA did not show similar results ( E, F ). Patients without MG showed higher CD55 mRNA and protein expression levels than those with MG, however, this difference was not statistically significant ( G ). There was also no statistically significant relationship between tumor diameter and CD55 expression ( H ). When CD55 protein was highly expressed, the mRNA level was also high ( I ).

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Expressing, Adjuvant

Journal: World Journal of Surgical Oncology

Article Title: CD55 may be an important prognostic factor of thymic epithelial tumors: a retrospective study

doi: 10.1186/s12957-025-04051-2

Figure Lengend Snippet: Kaplan-Meier Survival Analysis in high-risk TETs The results demonstrated that PFS of high-risk TETs was closely related to high expression of CD55 mRNA (A, p < 0.0001) and CD55 protein (B, p = 0.0168)

Article Snippet: The primary rabbit anti-human CD55 polyclonal antibody (Proteintech, USA) was diluted at a ratio of 1:1400.

Techniques: Expressing

Journal: American Journal of Clinical and Experimental Urology

Article Title: Estrogen receptor alpha differentially modulates host immunity in the bladder and kidney in response to urinary tract infection

doi:

Figure Lengend Snippet: CD55 expression at 2 day versus 6 day pi in bladder and kidney after (A) PPT and (C) MPP treatment in mice (N = 10 to 12 mice per treatment group, each with two time points). Representative images (40X) of bladder and kidney tissue sections showing CD55 protein expression after (B) PPT and (D) MPP treatment (E: Epithelium, LP: Lamina, Propria, M: Muscularis, T: Tubules, G: Glomerulus, GH: Glomerular Head, B: Bowman’s Capsule). (A) After PPT treatment, no change in CD55 expression was observed in kidney, while CD55 expression in bladder was considerably high (C) After MPP treatment, CD55 levels were considerably low in bladder but comparatively higher in kidney.

Article Snippet: Tissue sections were incubated in 5% horse serum followed by overnight incubation at 4°C with primary antibodies that include rabbit polyclonal anti-mouse CD55 antibody (H-319, Catalog # sc-9156 from Santa Cruz Biotechnology, Santa Cruz, CA) or with goat polyclonal anti-mouse TNFα antibody (Catalog # AF-410-NA from R&D systems, Minneapolis, MN).

Techniques: Expressing

Journal: American Journal of Clinical and Experimental Urology

Article Title: Estrogen receptor alpha differentially modulates host immunity in the bladder and kidney in response to urinary tract infection

doi:

Figure Lengend Snippet: Expression of cd55 mRNA in kidney after (A) PPT treatment and (B) MPP treatment (N = 10 to 12 mice per treatment group, each with two time points). (A) No changes in CD55 mRNA copy numbers were observed after PPT treatment. (B) However, MPP treatment reduced CD55 mRNA copy numbers at 6 days pi.

Article Snippet: Tissue sections were incubated in 5% horse serum followed by overnight incubation at 4°C with primary antibodies that include rabbit polyclonal anti-mouse CD55 antibody (H-319, Catalog # sc-9156 from Santa Cruz Biotechnology, Santa Cruz, CA) or with goat polyclonal anti-mouse TNFα antibody (Catalog # AF-410-NA from R&D systems, Minneapolis, MN).

Techniques: Expressing

Journal: American Journal of Clinical and Experimental Urology

Article Title: Estrogen receptor alpha differentially modulates host immunity in the bladder and kidney in response to urinary tract infection

doi:

Figure Lengend Snippet: CD55 expression at 2 day versus 6 day pi in bladder and kidney after (A) PPT and (C) MPP treatment in mice (N = 10 to 12 mice per treatment group, each with two time points). Representative images (40X) of bladder and kidney tissue sections showing CD55 protein expression after (B) PPT and (D) MPP treatment (E: Epithelium, LP: Lamina, Propria, M: Muscularis, T: Tubules, G: Glomerulus, GH: Glomerular Head, B: Bowman’s Capsule). (A) After PPT treatment, no change in CD55 expression was observed in kidney, while CD55 expression in bladder was considerably high (C) After MPP treatment, CD55 levels were considerably low in bladder but comparatively higher in kidney.

Article Snippet: Tissue sections were incubated in 5% horse serum followed by overnight incubation at 4°C with primary antibodies that include rabbit polyclonal anti-mouse CD55 antibody (H-319, Catalog # sc-9156 from Santa Cruz Biotechnology, Santa Cruz, CA) or with goat polyclonal anti-mouse TNFα antibody (Catalog # AF-410-NA from R&D systems, Minneapolis, MN).

Techniques: Expressing

Journal: American Journal of Clinical and Experimental Urology

Article Title: Estrogen receptor alpha differentially modulates host immunity in the bladder and kidney in response to urinary tract infection

doi:

Figure Lengend Snippet: Expression of cd55 mRNA in kidney after (A) PPT treatment and (B) MPP treatment (N = 10 to 12 mice per treatment group, each with two time points). (A) No changes in CD55 mRNA copy numbers were observed after PPT treatment. (B) However, MPP treatment reduced CD55 mRNA copy numbers at 6 days pi.

Article Snippet: Tissue sections were incubated in 5% horse serum followed by overnight incubation at 4°C with primary antibodies that include rabbit polyclonal anti-mouse CD55 antibody (H-319, Catalog # sc-9156 from Santa Cruz Biotechnology, Santa Cruz, CA) or with goat polyclonal anti-mouse TNFα antibody (Catalog # AF-410-NA from R&D systems, Minneapolis, MN).

Techniques: Expressing